CORONA Remedies Ltd

NSE: CORONA | BSE: 544644

₹2,098.80

up-down-arrow7.70 (0.37%)

As on 31-Jul-2026IST

Market cap

info icon

₹12,829 Cr

Revenue (TTM)

info icon

₹1,479 Cr

P/E Ratio

info icon

64.5

P/B Ratio

info icon

17.2

Div. Yield

info icon

0.5 %

Value Research Rating

Quality Score fund-quick-summary-circle

Quality Score10/10

Growth Score fund-quick-summary-circle

Growth Score8/10

Valuation Score fund-quick-summary-circle

Valuation Score2/10

Momentum Score fund-quick-summary-circle

Momentum Score10/10

CORONA Remedies Share Price

Compare

High: Low: Return:

High: Low: Return:

Max: Min: Median:

Max: Min: Median:

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 2,077.60 High: 2,136.00

52 Week Range

Low: 1,336.60 High: 2,145.90

Liquidityliquidity High

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    ₹199 Cr

  • ROEROE information

    27.4 %

  • ROCEROCE information

    31.7 %

  • Industry P/EIndustry P/E information

    38.04

  • EV/EBITDAEV/EBITDA information

    39.3

  • Debt to EquityDebt to Equity information

    0.2

  • Book ValueBook Value information

    ₹122.1

  • EPSEPS information

    ₹34.9

  • Face valueFace value information

    10

  • Shares outstandingShares outstanding information

    61,160,088

6 Years Aggregate

CFO

₹622.78 Cr

EBITDA

₹939.34 Cr

Net Profit

₹579.53 Cr

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
CORONA Remedies
51.5 6.6 24.2 -- -- -- --
BSE Healthcare
17.0 3.6 13.8 10.8 22.3 14.2 12.0
As on 31-Jul-2026
The underlying data is unavailable.

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

loading...

*All values are in (₹ Cr)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price (₹) Market Cap (₹ Cr) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
CORONA Remedies
2,098.8 12,828.9 1,479.1 198.6 18.6 30.3 64.5 17.2
8,100.0 20,259.1 2,275.6 187.5 10.3 23 108 23.4
2,516.8 19,114.7 2,187.2 649.7 31.5 19 29.8 5.3
1,354.7 18,746.9 3,229.7 666.9 26.6 18.8 29.1 4.6
2,408.9 38,730.8 4,147.8 709.5 22.3 19.1 54.6 9.3
4,823.9 22,063.2 2,569.8 735.2 34.4 19.2 30 5.0
6,604.5 10,951.4 1,408.0 326.9 30.8 57.1 33.5 20.9
3,318.0 7,646.6 1,773.8 309.8 24.0 43.1 24.7 9.8
611.3 11,960.8 1,538.1 226.2 20.4 9 49.2 4.6
1,025.0 9,431.6 5,004.4 635.3 14.5 19.8 15.4 3.0

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

News & Analysis

All News

About CORONA Remedies

--

  • Incorporated

    2004

  • Chairman

    Kirti Mehta

  • Managing Director

    Nirav Mehta

  • Headquarters

    Ahmedabad, Gujarat

  • Website

    www.coronaremedies.com

Edit peer-selector-edit

FAQs for CORONA Remedies

The share price of CORONA Remedies Ltd is ₹2,098.80 (NSE) and ₹2,097.60 (BSE) as of 31-Jul-2026 IST. CORONA Remedies Ltd has given a return of --% in the last 1 years.

The P/E ratio of CORONA Remedies Ltd is 64.46 times as on 31-Jul-2026, a 69 premium to its peers’ median range of 38.04 times.
The P/B ratio of CORONA Remedies Ltd is 17.18 times as on 31-Jul-2026, a 244 premium to its peers’ median range of 4.99 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2026
51.41
12.74
2025
0.00
0.00
2024
0.00
0.00
2023
0.00
0.00
2022
0.00
0.00

The 52-week high and low of CORONA Remedies Ltd are Rs 2,145.90 and Rs 1,336.60 as of 01-Aug-2026.

CORONA Remedies Ltd has a market capitalisation of ₹ 12,829 Cr as on 31-Jul-2026. As per SEBI classification, it is a Small Cap company.

Before investing in CORONA Remedies Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.